Markets · Europe · Swiss

NOVN.SW Novartis International AG

CHF 117.72 -1.92%

Europe · Health care

Log

Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.

-1.92%

YTD

+10.50%

P/E

—

P/B

—

ROE

—

Div yield

—

Beta

0.05

Market cap

—

RSI (14)

Next earnings

—

Previous session

close of Oct 8, 2026 · EOD, no live order book

Open

CHF 119.08

CHF 117.72

VWAP (n/a)

—

Day high

CHF 119.36

Day low

CHF 117.26

Volume

3.9M

VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.

Latest headlines

Former Highflier Argenx Plummets On A Surprise Setback In Sjogren's

Yahoo Finance · Oct 8

Argenx Stock Sinks on Scrapped Autoimmune Drug Trial. Why the Selloff Is Overdone.

Yahoo Finance · Oct 8

NVS Wins FDA Nod for Label Expansion of Immunology Drug Rhapsido

Yahoo Finance · Oct 8

Pheochromocytoma and Paraganglioma (PCPG) Market to Reach US$670 Million by 2036 at 7.3% CAGR, Driven by Targeted and Radioligand Therapies

Yahoo Finance · Oct 8

Is Novartis (SWX:NOVN) Undervalued After New MS Trial Data Took Center Stage?

Yahoo Finance · Oct 7

Sector Update: Healthcare Stocks Rise Late Afternoon

Yahoo Finance · Oct 7

Headlines via Yahoo Finance · links open the source · not an endorsement.

Research & reports

TradingView ↗

Charts & analysis

Yahoo Finance ↗

Quote & news

External resources — availability and opinions are theirs, not ours.

This is reference data for your own analysis — not a recommendation to buy or sell NOVN.SW. Try it in the Lab to size a position and see the risk.